Skip to main content
Erschienen in: International Journal of Clinical Oncology 8/2019

20.03.2019 | Original Article

Removal of the entire internal iliac vessel system is a feasible surgical procedure for locally advanced ovarian carcinoma adhered firmly to the pelvic sidewall

verfasst von: Kyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, Makio Shozu

Erschienen in: International Journal of Clinical Oncology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Ovarian carcinomas sometimes grow in the pelvic cavity, adhering firmly to the pelvic sidewall. These cases are often considered as inoperable or result in the incomplete resection because the tumors are not mobile. We performed en bloc resection of the tumors along with the entire internal iliac vessel system to achieve complete resection.

Methods

Twenty of 237 consecutive patients with FIGO stage II–IV ovarian, fallopian tubal, or primary peritoneal carcinoma who underwent cytoreductive surgery at Chiba University Hospital between January 2008 and December 2016 had locally advanced tumors adhered firmly to the pelvic sidewall. We performed isolation of the tumors from the pelvic sidewall using the following procedure: the trunk of internal iliac vessels, the obturator vessels, the inferior gluteal and internal pudendal vessels were isolated and divided. The tumor together with the entire internal iliac vessel system was isolated from the sacral nerve plexus and piriform muscle. We examined the surgical outcomes, perioperative complications, and prognosis for the patients who underwent this procedure.

Results

All patients successfully underwent complete resection, resulting in no gross residual disease in the pelvic cavity. There was no mortality within 90 days postoperatively. Two patients had Grade IIIb complications, comprising wound dehiscence and vesicovaginal fistula. Recurrence occurred in nine of the patients. However, no recurrence was observed in the pelvic sidewall. The median progression-free survival was 43 months.

Conclusions

Removal of the entire internal iliac vessel system is feasible for the complete resection of locally advanced ovarian carcinomas adhered firmly to the pelvic sidewall.
Literatur
1.
Zurück zum Zitat Griffiths CT (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42:101–104PubMed Griffiths CT (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42:101–104PubMed
2.
Zurück zum Zitat Eisenkop SM, Friedman RL, Wang HJ (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 69(2):103–108CrossRefPubMed Eisenkop SM, Friedman RL, Wang HJ (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 69(2):103–108CrossRefPubMed
3.
Zurück zum Zitat Chi DS, Eisenhauer EL, Lang J et al (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103(2):559–564CrossRefPubMed Chi DS, Eisenhauer EL, Lang J et al (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103(2):559–564CrossRefPubMed
4.
Zurück zum Zitat Chi DS, Eisenhauer EL, Zivanovic O et al (2009) Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 114(1):26–31CrossRefPubMed Chi DS, Eisenhauer EL, Zivanovic O et al (2009) Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 114(1):26–31CrossRefPubMed
5.
Zurück zum Zitat Kehoe SM, Eisenhauer EL, Chi DS (2008) Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy. Gynecol Oncol 111(2 Suppl):S51–S55CrossRefPubMed Kehoe SM, Eisenhauer EL, Chi DS (2008) Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy. Gynecol Oncol 111(2 Suppl):S51–S55CrossRefPubMed
6.
Zurück zum Zitat Aletti GD, Dowdy SC, Gostout BS et al (2006) Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 107(1):77–85CrossRefPubMed Aletti GD, Dowdy SC, Gostout BS et al (2006) Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 107(1):77–85CrossRefPubMed
7.
Zurück zum Zitat Cliby W, Dowdy S, Feitoza SS et al (2004) Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol 94(3):655–660CrossRefPubMed Cliby W, Dowdy S, Feitoza SS et al (2004) Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol 94(3):655–660CrossRefPubMed
8.
Zurück zum Zitat McCann CK, Growdon WB, Munro EG et al (2011) Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer. Ann Surg Oncol 18(10):2912–2918CrossRefPubMed McCann CK, Growdon WB, Munro EG et al (2011) Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer. Ann Surg Oncol 18(10):2912–2918CrossRefPubMed
9.
Zurück zum Zitat Pawlik TM, Skibber JM, Rodriguez-Bigas MA (2006) Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol 13(5):612–623CrossRefPubMed Pawlik TM, Skibber JM, Rodriguez-Bigas MA (2006) Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol 13(5):612–623CrossRefPubMed
10.
Zurück zum Zitat Mibayashi R (1941) Hukushiki-Choukouhannsei-sikyuukeigantekisyutsuzyutsu (in Japanese). (Abdominal super-radical hysterectomy). J Jpn Obstet Gynecol Soc, p 480 Mibayashi R (1941) Hukushiki-Choukouhannsei-sikyuukeigantekisyutsuzyutsu (in Japanese). (Abdominal super-radical hysterectomy). J Jpn Obstet Gynecol Soc, p 480
11.
Zurück zum Zitat Mibayashi R (1970) Mibayashi-Zyutsushiki (in Japanese). (Mibayashi’s super-radical hysterectomy). Gendai-sankahuzinka-taikei 8E Tokyo: Nakayama-Shoten Co., pp 269–279 Mibayashi R (1970) Mibayashi-Zyutsushiki (in Japanese). (Mibayashi’s super-radical hysterectomy). Gendai-sankahuzinka-taikei 8E Tokyo: Nakayama-Shoten Co., pp 269–279
12.
Zurück zum Zitat Ungar L, Palfalvi L (2003) Surgical treatment of lymph node metastases in stage IB cervical cancer: the laterally extended parametrectomy (LEP) procedure. Int J Gynecol Cancer 13(5):647–651CrossRefPubMed Ungar L, Palfalvi L (2003) Surgical treatment of lymph node metastases in stage IB cervical cancer: the laterally extended parametrectomy (LEP) procedure. Int J Gynecol Cancer 13(5):647–651CrossRefPubMed
13.
Zurück zum Zitat Palfalvi L, Ungar L (2003) Laterally extended parametrectomy (LEP), the technique for radical pelvic side wall dissection: feasibility, technique and results. Int J Gynecol Cancer 13(6):914–917CrossRefPubMed Palfalvi L, Ungar L (2003) Laterally extended parametrectomy (LEP), the technique for radical pelvic side wall dissection: feasibility, technique and results. Int J Gynecol Cancer 13(6):914–917CrossRefPubMed
14.
Zurück zum Zitat Ungar L, Palfalvi L, Tarnai L et al (2011) Surgical treatment of lymph node metastases in stage IB cervical cancer. The laterally extended parametrectomy (LEP) procedure: experience with a 5 year follow-up. Gynecol Oncol 123(2):337–341CrossRefPubMed Ungar L, Palfalvi L, Tarnai L et al (2011) Surgical treatment of lymph node metastases in stage IB cervical cancer. The laterally extended parametrectomy (LEP) procedure: experience with a 5 year follow-up. Gynecol Oncol 123(2):337–341CrossRefPubMed
15.
Zurück zum Zitat Höckel M (1999) Laterally extended endopelvic resection: surgical treatment of infrailiac pelvic wall recurrences of gynecologic malignancies. Am J Obstet Gynecol 180(2 Pt 1):306–312CrossRefPubMed Höckel M (1999) Laterally extended endopelvic resection: surgical treatment of infrailiac pelvic wall recurrences of gynecologic malignancies. Am J Obstet Gynecol 180(2 Pt 1):306–312CrossRefPubMed
16.
Zurück zum Zitat Höckel M (2003) Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecol Oncol 91(2):369–377CrossRefPubMed Höckel M (2003) Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecol Oncol 91(2):369–377CrossRefPubMed
17.
Zurück zum Zitat Höckel M (2008) Laterally extended endopelvic resection (LEER)--principles and practice. Gynecol Oncol 111(2 Suppl):S13–S17CrossRefPubMed Höckel M (2008) Laterally extended endopelvic resection (LEER)--principles and practice. Gynecol Oncol 111(2 Suppl):S13–S17CrossRefPubMed
18.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Vergote I, Amant F, Kristensen G et al (2011) Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer. Eur J Cancer 47(Suppl 3):S88–S92CrossRefPubMed Vergote I, Amant F, Kristensen G et al (2011) Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer. Eur J Cancer 47(Suppl 3):S88–S92CrossRefPubMed
20.
Zurück zum Zitat Hynninen J, Lavonius M, Oksa S et al (2013) Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy? Gynecol Oncol 128(2):229–232CrossRefPubMed Hynninen J, Lavonius M, Oksa S et al (2013) Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy? Gynecol Oncol 128(2):229–232CrossRefPubMed
21.
Zurück zum Zitat Le T, Williams K, Senterman M et al (2007) Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking. Gynecol Oncol 106(1):160–163CrossRefPubMed Le T, Williams K, Senterman M et al (2007) Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking. Gynecol Oncol 106(1):160–163CrossRefPubMed
22.
Zurück zum Zitat Vergote I, du Bois A, Amant F et al (2013) Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree? Gynecol Oncol 128(1):6–11CrossRefPubMed Vergote I, du Bois A, Amant F et al (2013) Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree? Gynecol Oncol 128(1):6–11CrossRefPubMed
23.
Zurück zum Zitat Oderich GS, Panneton JM, Hofer J et al (2004) Iatrogenic operative injuries of abdominal and pelvic veins: a potentially lethal complication. J Vasc Surg 39(5):931–936CrossRefPubMed Oderich GS, Panneton JM, Hofer J et al (2004) Iatrogenic operative injuries of abdominal and pelvic veins: a potentially lethal complication. J Vasc Surg 39(5):931–936CrossRefPubMed
24.
Zurück zum Zitat Nishikimi K, Tate S, Matsuoka A et al (2017) Complete resection of locally advanced ovarian carcinoma fixed to the pelvic sidewall and involving external and internal iliac vessels. Gynecol Oncol 146(2):436–437CrossRefPubMed Nishikimi K, Tate S, Matsuoka A et al (2017) Complete resection of locally advanced ovarian carcinoma fixed to the pelvic sidewall and involving external and internal iliac vessels. Gynecol Oncol 146(2):436–437CrossRefPubMed
25.
Zurück zum Zitat Tentes AA, Tripsiannis G, Markakidis SK et al (2003) Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol 29(1):69–73CrossRefPubMed Tentes AA, Tripsiannis G, Markakidis SK et al (2003) Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol 29(1):69–73CrossRefPubMed
26.
Zurück zum Zitat Gasimli K, Braicu EI, Richter R et al (2015) Prognostic and predictive value of the peritoneal cancer index in primary advanced epithelial ovarian cancer patients after complete cytoreductive surgery: study of tumor bank ovarian cancer. Ann Surg Oncol 22(8):2729–2737CrossRefPubMed Gasimli K, Braicu EI, Richter R et al (2015) Prognostic and predictive value of the peritoneal cancer index in primary advanced epithelial ovarian cancer patients after complete cytoreductive surgery: study of tumor bank ovarian cancer. Ann Surg Oncol 22(8):2729–2737CrossRefPubMed
27.
Zurück zum Zitat Wright A, Bohlke K, Armstrong DK et al (2016) Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: society of gynecologic oncology and American society of clinical oncology clinical practice guideline. Gynecol Oncol 143(1):3–15CrossRefPubMedPubMedCentral Wright A, Bohlke K, Armstrong DK et al (2016) Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: society of gynecologic oncology and American society of clinical oncology clinical practice guideline. Gynecol Oncol 143(1):3–15CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Komiyama S, Katabuchi H, Mikami M et al (2016) Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer. Int J Clin Oncol 21(3):435–446CrossRefPubMed Komiyama S, Katabuchi H, Mikami M et al (2016) Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer. Int J Clin Oncol 21(3):435–446CrossRefPubMed
Metadaten
Titel
Removal of the entire internal iliac vessel system is a feasible surgical procedure for locally advanced ovarian carcinoma adhered firmly to the pelvic sidewall
verfasst von
Kyoko Nishikimi
Shinichi Tate
Ayumu Matsuoka
Makio Shozu
Publikationsdatum
20.03.2019
Verlag
Springer Singapore
Erschienen in
International Journal of Clinical Oncology / Ausgabe 8/2019
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-019-01429-7

Weitere Artikel der Ausgabe 8/2019

International Journal of Clinical Oncology 8/2019 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.